PubMed Health⌕ Search

PubMed · 12647559

[Aspergillus, aspergillosis].

Abstract

Aspergillus is a ubiquitous fungus which can penetrate into the human body in a natural way, by the respiratory tract or traumatically or iatrogenically. The presence of Aspergillus in the atmosphere is constant, in the environment, especially in moist places or in the neighbourhood of man, in dust. Aspergillus can colonise different substrates, the organic rests, soil, plants, cloting, climatisation, furniture. Aspergillus is in the first phase among the agents responsible for respiratory infections, for different physiopathological mechanisms and for some nosocomial infections. The author gives a review of sources of Aspergillus, especially for hospitalized patients, of mechanisms of the host's defence, of factors enabling the survival of Aspergillus in hosts and of clinical picture. The prevalence of deep forms: aspergillome, allergic bronchopulmonal aspergillosis remain constant. New clinical forms appear due to modern therapy (immunosuppression, organ transplantation). The author describes further laboratory diagnostics with the interpretation of results and epidemiological studies. The early diagnostics of different types of aspergillosis, preventive methods and actual antimycotic therapy can inhibit the progress and improve the prognosis of these infectious diseases.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Tomsíková. 2003. [Aspergillus, aspergillosis].. https://pubmed.ncbi.nlm.nih.gov/12647559/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis.

Tumor necrosis factor alpha (TNF-alpha) and lymphotoxin alpha (LT-alpha) are pivotal mediators of inflammatory responses in fungal infection diseases. We hypothesized that polymorphisms in genes of these cytokines or their receptors might increase the susceptibility of hematologic patients to develop invasive pulmonary aspergillosis (IPA). One hundred two hematologic patients and 124 age-matched controls were enrolled in the study, and the following standard single nucleotide polymorphisms were investigated: TNF-alpha -308 and +489, LT-alpha +252 and Tumor Necrosis Factor Receptor 2 (TNFR2) +676. Variable number of tandem repeats (VNTRs) at position -322 of the TNFR2 gene were also studied. Genotypic and allelic frequencies were similar between patients and controls. IPA was diagnosed in 54 of the 102 patients according to consensus criteria published by the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group. TNF-alpha and LT-alpha polymorphisms were not associated with presence of IPA. Susceptibility to IPA was strongly associated with VNTR at position -322 in the promoter region of the TNR2 gene (p = 0.029) but was not associated with the presence of TNFR2 +676 polymorphism. A genetic difference in TNFR2 promoter VNTR may play a major role in susceptibility to IPA infection.

Aspergillosis↗